Rivastigmine Tartrate
Rivastigmine tartrate is an AchR inhibitor use for treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease with elimination half-life of 1.5 hours.
| Trivial name | ENA 713 Tartrate; SDZ-ENA-713 Tartrate |
| Catalog Number | CSN11852 |
| Alternative Name(s) | ENA 713 Tartrate; SDZ-ENA-713 Tartrate |
| Research Area | Neurological Disease |
| Molecular Formula | C18H28N2O8 |
| CAS# | 129101-54-8 |
| Purity | ≥99% |
| SMILES | O=C(O)[C@H](O)[C@@H](O)C(O)=O.O=C(OC1=CC=CC([C@@H](N(C)C)C)=C1)N(CC)C |
| Size | 250mg |
| Supplier Page | https://www.csnpharm.com/products/rivastigmine-tartrate.html |